Brief: Seres Therapeutics Prelim Year-End 2023 Cash Balance Of About $128 Mln
Jan 9 (Reuters) - Seres Therapeutics Inc MCRB.O :
* SERES THERAPEUTICS INC: PRELIM YEAR-END 2023 CASH BALANCE
OF
ABOUT $128 MILLION
Further company coverage: MCRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47